Studies have reported the expression of RANKL in osteosarcoma, and the proportion ranges from 8.8% to 75% (Lee et al., 2011; Bago-Horvath et al., 2014; Branstetter et al., 2015). The gene discussed is TNFSF11; the disease is osteosarcoma.